3-nitroso-2-oxazolidone: structure given in first source
ID Source | ID |
---|---|
PubMed CID | 148247 |
CHEMBL ID | 12205 |
SCHEMBL ID | 2346858 |
MeSH ID | M0111129 |
Synonym |
---|
3-nitroso-2-oxazolidinone |
38347-74-9 |
3-nitroso-1,3-oxazolidin-2-one |
ccris 5276 |
2-oxazolidinone, 3-nitroso- |
3-nitroso-2-oxazolidone |
CHEMBL12205 |
8u5ujn2h6w , |
unii-8u5ujn2h6w |
SCHEMBL2346858 |
DTXSID9021007 |
n-nitroso-oxazolidin-2-one |
nitroso-2-oxazolidinone, 3- |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID24145 | Half life was determined | 1985 | Journal of medicinal chemistry, Aug, Volume: 28, Issue:8 | Decomposition reactions of (hydroxyalkyl) nitrosoureas and related compounds: possible relationship to carcinogenicity. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.19) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |